Search Results

Hospital for Special Surgery, the world’s leading musculoskeletal health institution, has received support from Schmidt Futures to advance its research and development efforts in artificial intelligence and machine learning.

Hospital for Special Surgery and NCH Healthcare System announced that David L. Helfet, MD, renowned HSS orthopedic trauma surgeon, has been appointed Executive Medical Director of HSS at NCH, the collaboration formed to bring high quality orthopedic care to southwest Florida.

Asensus Surgical, Inc. announced that St. Marianna University School of Medicine Yokohama City Seibu Hospital in Japan has entered into an agreement to lease and utilize a Senhance® Surgical System in the Urology and Gastroenterology/General Surgery department.

Hospital for Special Surgery announced that Bryan T. Kelly, MD, MBA will succeed President and Chief Executive Officer Louis A. Shapiro in a phased transition over the course of 2023, becoming the first surgeon to lead the 160-year-old academic medical system specialized in musculoskeletal health.

OrthAlign, Inc. is celebrating the 16,500th procedure at Hospital for Special Surgery with 25 of its surgeons using its technology in hip and knee replacements.

LSL PHARMA GROUP INC., a Canadian integrated pharmaceutical company, is pleased to announce the results of its annual and special meeting of shareholders held in Montréal, Québec.

Arch Biopartners Inc. , (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today that a research team from St. Michael’s Hospital, a site of Unity Health Toronto, has joined the Phase II trial for LSALT peptide targeting the prevention and treatment of cardiac surgery-associated acute kidney injury (CS-AKI).